Human monoclonal antibodies to prostate specific membrane antigen (PSMA)

Details for Australian Patent Application No. 2003224604 (hide)

Owner Medarex, Inc.

Inventors Deo, Yashwant M; Black, Amelia; Tino, William T; Hudson, Debra; Graziano, Robert; Holmes, Eric H

Agent Shelston IP

Pub. Number AU-B-2003224604

PCT Number PCT/US03/02448

PCT Pub. Number WO2003/064606

Priority 10/059,989 28.01.02 US

Filing date 28 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 14 June 2007

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 10/059,989 28.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003224604

14 June 2007 Application Accepted

  Published as AU-B-2003224604

11 October 2007 Standard Patent Sealed

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224605-ULTRAVIOLET PROTECTED MULTILAYER STRUCTURES OF COPOLYESTER/POLYCARBONATE BLENDS

2003224603-POTENTIATION OF CANCER THERAPIES BY ZNF217 INHIBITION